USPTO serial 88006247
Reviewed by CopyMark Law Group
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
| Class | Description | Status | First use |
|---|---|---|---|
| 035 | Promoting collaboration of clinical research sites in designing and conducting pediatric clinical trials to achieve advances in the field of healthcare; Promoting collaboration of clinical research sites to improve healthcare for pediatric patients; Providing administrative and management services to support clinical trial programs in the field of pediatrics, namely, business administration services and business management | ACTIVE | Sep 30, 2011 |
| 042 | Medical research; Pharmaceutical research services; Medical and scientific research in the field of development of medications and medical devices for use in pediatric patients; Clinical research in the field of development of medications and medical devices for use in pediatric patients; Conducting clinical trials for others; Consulting services for others in the field of design, planning, and implementation project management of pediatric clinical trials; Providing medical and scientific research information in the field of development of pediatric medications and medical devices, and clinical trials | ACTIVE | Sep 30, 2011 |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| Sep 25, 2019 | MAB1 | ABANDONMENT NOTICE E-MAILED - EXPRESS ABANDONMENT | — |
| Sep 25, 2019 | ABN1 | ABANDONMENT - EXPRESS MAILED | — |
| Sep 24, 2019 | EXAR | TEAS EXPRESS ABANDONMENT RECEIVED | — |
| Sep 24, 2019 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Sep 23, 2019 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Sep 23, 2019 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Mar 23, 2019 | GPRN | NOTIFICATION OF PRIORITY ACTION E-MAILED | A priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline. |
| Mar 23, 2019 | GPRA | PRIORITY ACTION E-MAILED | A priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline. |
| Mar 23, 2019 | CPRA | PRIORITY ACTION WRITTEN | A priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline. |
| Mar 14, 2019 | ZZZX | PREVIOUS ALLOWANCE COUNT WITHDRAWN | — |
| Mar 12, 2019 | PBCR | WITHDRAWN FROM PUB - OG REVIEW QUERY | — |
| Feb 22, 2019 | ALIE | ASSIGNED TO LIE | — |
| Feb 6, 2019 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Feb 6, 2019 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Feb 6, 2019 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Feb 6, 2019 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Feb 6, 2019 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Jan 4, 2019 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jan 4, 2019 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jan 4, 2019 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Oct 15, 2018 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 15, 2018 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 15, 2018 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 6, 2018 | DOCK | ASSIGNED TO EXAMINER | — |
| Jun 26, 2018 | MDSM | NOTICE OF DESIGN SEARCH CODE E-MAILED | — |
| Jun 25, 2018 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jun 22, 2018 | NWAP | NEW APPLICATION ENTERED | — |